Vensana Capital recently announced that it has closed a $425 million Fund III for continued investment in innovative medtech ...
CapsoVision announced today that the FDA cleared its CapsoCam Plus system for use in pediatric patients aged two and above.
Pulse Biosciences announced today that it appointed Paul A. LaViolette, co-chair of its board, as its new CEO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback